Sustained remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation who were naive to anti-TNF treatment: 4-year results from PRECiSE 4.

被引：0
|
作者：
Sandborn, W. [1 ]
Schreiber, S. [2 ]
Hanauer, S. [3 ]
Colombel, J. [4 ]
Bloomfield, R. [5 ]
Lichtenstein, G. [6 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Kiel, Kiel, Germany
[3] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[4] Hop Claude Huriez, Lille, France
[5] UCB Pharma, Slough, Berks, England
[6] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 10 条
  • [1] Sustained Remission With No Dose Escalation After Re-Induction With Certolizumab Pegol in Patients With Crohn's Disease Exacerbation Who Were NaiVE to Anti-TNF Treatment: 5-Year Results From Precise 4
    Sandborn, William J.
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Sen, David L.
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S65 - S66
  • [2] Sustained remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation who were naive to anti-TNF treatment: 5-year results from PRECiSE 4
    Sandborn, William J.
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Sen, David
    Lichtenstein, Gary R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S24 - S24
  • [3] Long-term Maintenance of Remission with No Dose Escalation After Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation Who Were Naive to Anti-TNF Treatment: 4-Year Results from the PRECiSE 4 Study
    Sandborn, William
    Schreiber, Stefan
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Bloomfield, Ralph
    Lichtenstein, Gary
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S418 - S418
  • [4] Sustained Remission with No Dose Escalation after Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation: 1-Year Results from PRECiSE 4
    Sandborn, William
    Rubin, David
    Sen, David
    Feagan, Brian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S439 - S439
  • [5] Long-term maintenance of remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation: 3-year results from the PRECiSE 4 study
    Sandborn, W.
    Schreiber, S.
    Hanauer, S.
    Colombel, J.
    Bloomfield, R.
    Lichtenstein, G.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S14 - S14
  • [6] Remission Rates in Crohn's Disease Patients Treated With a Re-Induction Regimen of Certolizumab Pegol After Experiencing Disease Exacerbation: 7 Year Results From the Precise 4 Study
    Lee, Scott D.
    Schreiber, Stefan
    Schwartz, David A.
    Burakoff, Robert
    Binion, David G.
    Kayhan, Cem
    Kosutic, Gordana
    Ambarkhane, Sumeet
    Sen, David
    Hasan, Iram
    Spearman, Marshall
    Sandborn, William
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S261 - S261
  • [7] Long-term Maintenance of Remission with No Dose Escalation Aft er Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation: 3-year Results from the PRECiSE 4 Study
    Sandborn, William
    Schreiber, Stefan
    Hanauer, Stephen
    Colombel, Jean-Frederick
    Bloomfield, Ralph
    Lichtenstein, Gary
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S448 - S448
  • [8] RE-induction and maintenance therapy with subcutaneous certolizumab pegial in patients with Crohn's disease following treatment failure: Precise 4 results
    Sandborn, William J.
    Hanauer, Stephen B.
    Rutgeerts, Paul J.
    Colombel, Jean-frederic
    Schreiber, Stefan
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A505 - A505
  • [9] Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study
    Lee, Scott D.
    Rubin, David T.
    Sandborn, William J.
    Randall, Charles
    Younes, Ziad
    Schreiber, Stefan
    Schwartz, David A.
    Burakoff, Robert
    Binion, David
    Dassopoulos, Themos
    Arsenescu, Razvan
    Gutierrez, Alexandra
    Scherl, Ellen
    Kayhan, Cem
    Hasan, Iram
    Kosutic, Gordana
    Spearman, Marshall
    Sen, David
    Coarse, Jason
    Hanauer, Stephen
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) : 1870 - 1880
  • [10] Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn's disease naive to anti-TNF agents
    Eder, Piotr
    Lykowska-Szuber, Liliana
    Katulska, Katarzyna
    Stawczyk-Eder, Kamila
    Krela-Kazmierczak, Iwona
    Klimczak, Katarzyna
    Szymczak, Aleksandra
    Stajgis, Marek
    Linke, Krzysztof
    [J]. GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2016, 11 (03): : 187 - 193
1